Memory stocks are going thru the biggest bubble we will see in our lifetime for them. A stock like Micron is just one of many. The party is NOT over yet, but when it does end… AND IT WILL… the mess to clean up will be gigantic.
BREAKING: Iran’s Speaker of the Parliament provides trading advice to investors trading US markets:
“Pre-market so-called ‘news’ or ‘Truth’ is often just a setup for profit-taking. Basically, it is a reverse indicator. Do the opposite: If they pump it, short it. If they dump it, go long. See something tomorrow? You know the drill.”
The market is punishing companies for spending on AI…
While ignoring the only thing that matters:
Demand is exceeding supply.
That’s not a warning sign.
That’s where the winners are built.
🚨 $HIMS CEO ANDREW DUDUM HAS ASSEMBLED ONE OF THE MOST EXTRAORDINARY LEADERSHIP TEAMS IN ALL OF HEALTHCARE
C-SUITE
CEO - Andrew Dudum - ex-Atomic Labs
CFO - Yemi Okupe - ex-Uber, Google
COO - Mike Chi - ex-Zola
CTO - Mo Elshenawy - ex-Cruise, Amazon
CCO - Kathryn Beiser - ex-Eli Lilly
Chief Policy Officer - Deb Autor - ex-FDA, AstraZeneca, Mylan
CPO - Dheerja Kaur - ex-Robinhood
CLO - Soleil Boughton - ex-Google
CMO - Dr. Pat Carroll - ex-Walgreens
CDO - Dan Kenger - ex-Gin Lane
BOARD OF DIRECTORS
Kåre Schultz - ex-Teva, Novo Nordisk
Dr. Toby Cosgrove - ex-Cleveland Clinic
Christopher Payne - ex-DoorDash, Tinder, eBay, Amazon, Microsoft
David Wells - ex-Netflix
Anja Manuel - ex-U.S. State Department
Christiane Pendarvis - ex-Savage X Fenty, Victoria's Secret, Gap
Andrea Perez - ex-Sony PlayStation, Nike/Jordan
🚨 BREAKING: $HIMS SHORTS ARE QUADRUPLING DOWN
According to Robinhood, 88 million shares are now short
42% of the float
Beyond belief, short interest has actually increased since the Hims x Novo deal
🤯🤯🤯
BREAKING: AI can now analyze any stock like a Wall Street analyst (for free).
Here are 10 insane Claude prompts that replace $2,000/month Bloomberg terminals (Save for later)
$LLY $NVO $HIMS
🚨 BREAKING: ANDREW HUBERMAN SAYS ELI LILLY IS WORKING TO MAKE PEPTIDES ILLEGAL TO PURCHASE
ALSO EXPECTS RETATRUTIDE TO BE A TRILLION-DOLLAR DRUG
🤯🤯🤯
This lady on cnbc just said “where do you look with tech valuations being high”… ah baby are you high? What you on?
SAAS stocks are trading cheapest ever
Nvidia is forward PE in 20s
Meta forward PE under 20
Amazon is up 26% the past 5 years!
Netflix forward PE 25.
Wake up
🚨 NEW EPISODE!!!
NOVO NORDISK SUES $HIMS -- PATENT ATTORNEY GASTON KROUB (@GKROUB) BREAKS IT DOWN
02:25 - Details of the lawsuit
07:41 - Why no preliminary injunction?
12:31 - Why did Novo file now vs. 8-9 months ago?
24:04 - Why did Novo file in Delaware?
29:21 - Likely timelines, chances of settlement or dismissal
33:20 - Worst-case scenarios
36:48 - Indemnification and supplier liability?
45:01 - FDA & DOJ pressure on compounded GLP-1s
49:46 - How Hims miscalculated the oral launch
55:00 - What to watch next
1/ What if I tell you that Hims & Hers $HIMS is going to trade north of $222/share by 2030?
And these numbers might be conservative!
Let's dive into HOW this is going to happen 👇